Janus Kinase inhibitors in dermatology: a review
Janus Kinases (JAKs) are a subset of cytoplasmic protein tyrosine kinases (TYK), crucial for the initiation of signaling pathways activated by cytokines through phosphorylation and activation of the signal transducer and activator of transcription (STAT) proteins. Selective JAK inhibitors can simult...
Saved in:
Main Authors: | Bárbara Vieira-Granja (Author), Sofia Magina (Author) |
---|---|
Format: | Book |
Published: |
Sociedade Portuguesa de Dermatologia e Venereologia,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Janus kinases: dermatological perspective, a review
by: Hanan R Nada, et al.
Published: (2020) -
Janus Associated Kinases Inhibitors in the Pharmacological Thera
by: Daniela Santos1, et al.
Published: (2017) -
Itch and Janus Kinase Inhibitors
by: Yujin Han, et al.
Published: (2023) -
Janus kinase inhibitors: jackpot or potluck?
by: Pavithran Keechilat, et al.
Published: (2012) -
The Upadacitinib - New Janus Kinase Inhibitor - Literature Review
by: Michalina Grzelka, et al.
Published: (2024)